ArticleGlycoconjugate journal2010

Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, irinotecan.

Huan He et al.PubMed ↗Publisher ↗

No numbers read from the abstract.